Literature DB >> 22154628

Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group Perspective.

Ralph M Meyer1, Heather A Stanton, Wendy R Parulekar, Fred Saad.   

Abstract

Year:  2011        PMID： 22154628      PMCID： PMC3235199          DOI： 10.5489/cuaj.11228

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  23 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

Review 2.  How can payback from health services research be assessed?

Authors:  M Buxton; S Hanney
Journal:  J Health Serv Res Policy       Date:  1996-01

3.  Adoption of adjuvant chemotherapy for non-small-cell lung cancer: a population-based outcomes study.

Authors:  Christopher M Booth; Frances A Shepherd; Yingwei Peng; Gail E Darling; Gavin Li; Weidong Kong; William J Mackillop
Journal:  J Clin Oncol       Date:  2010-06-21       Impact factor: 44.544

4.  Cancer: the road to Amiens.

Authors:  David J Stewart; Razelle Kurzrock
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

5.  Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change.

Authors:  Bryan R Luce; Judith M Kramer; Steven N Goodman; Jason T Connor; Sean Tunis; Danielle Whicher; J Sanford Schwartz
Journal:  Ann Intern Med       Date:  2009-06-30       Impact factor: 25.391

Review 6.  Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

Authors:  Jean Bourhis; Jens Overgaard; Hélène Audry; Kian K Ang; Michele Saunders; Jacques Bernier; Jean-Claude Horiot; Aurélie Le Maître; Thomas F Pajak; Michael G Poulsen; Brian O'Sullivan; Werner Dobrowsky; Andrzej Hliniak; Krzysztof Skladowski; John H Hay; Luiz H J Pinto; Carlo Fallai; Karen K Fu; Richard Sylvester; Jean-Pierre Pignon
Journal:  Lancet       Date:  2006-09-02       Impact factor: 79.321

7.  Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

Authors:  Pamela J Goodwin; Marguerite Ennis; Kathleen I Pritchard; Maureen E Trudeau; Jarley Koo; Yolanda Madarnas; Warren Hartwick; Barry Hoffman; Nicky Hood
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

8.  Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

Authors:  Chang-Qi Zhu; Keyue Ding; Dan Strumpf; Barbara A Weir; Matthew Meyerson; Nathan Pennell; Roman K Thomas; Katsuhiko Naoki; Christine Ladd-Acosta; Ni Liu; Melania Pintilie; Sandy Der; Lesley Seymour; Igor Jurisica; Frances A Shepherd; Ming-Sound Tsao
Journal:  J Clin Oncol       Date:  2010-09-07       Impact factor: 44.544

9.  Pain flare following external beam radiotherapy and meaningful change in pain scores in the treatment of bone metastases.

Authors:  Edward Chow; Alison Ling; Lori Davis; Tony Panzarella; Cyril Danjoux
Journal:  Radiother Oncol       Date:  2005-03-16       Impact factor: 6.280

10.  Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.

Authors:  Padraig Warde; Malcolm Mason; Keyue Ding; Peter Kirkbride; Michael Brundage; Richard Cowan; Mary Gospodarowicz; Karen Sanders; Edmund Kostashuk; Greg Swanson; Jim Barber; Andrea Hiltz; Mahesh K B Parmar; Jinka Sathya; John Anderson; Charles Hayter; John Hetherington; Matthew R Sydes; Wendy Parulekar
Journal:  Lancet       Date:  2011-11-02       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.